Kevin Tan - Chief Financial Officer at Cartesian Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
RNAC on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Kevin Tan since 09 Sep 2025

Reported holdings for Kevin Tan in Cartesian Therapeutics, Inc.

Form 4 holding Chief Financial Officer

SELECTA BIOSCIENCES INC

Security class
Employee Stock Option (right to buy)
Shares / value
340,000
Estimated value
$268,600
Report date
03 Jan 2022
Price
$0.7900
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

SELECTA BIOSCIENCES INC

Security class
Common Stock
Shares / value
77,000
Estimated value
$158,620
Report date
03 Jan 2022
Price
$2.06
Ownership
Direct

Transaction history for Kevin Tan in Cartesian Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .